2024-04-01 2025-03-31 false No description of principal activity Capium Accounts Production 1.1 11975057 2024-04-01 2025-03-31 11975057 bus:AbridgedAccounts 2024-04-01 2025-03-31 11975057 bus:FRS102 2024-04-01 2025-03-31 11975057 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 11975057 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 11975057 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 11975057 2024-04-01 2025-03-31 11975057 2025-03-31 11975057 bus:RegisteredOffice 2024-04-01 2025-03-31 11975057 core:WithinOneYear 2025-03-31 11975057 core:AfterOneYear 2025-03-31 11975057 1 2024-04-01 2025-03-31 11975057 bus:Director1 2024-04-01 2025-03-31 11975057 bus:Director1 2025-03-31 11975057 bus:Director1 2023-06-01 2024-03-31 11975057 2023-06-01 11975057 bus:LeadAgentIfApplicable 2024-04-01 2025-03-31 11975057 2023-06-01 2024-03-31 11975057 2024-03-31 11975057 core:WithinOneYear 2024-03-31 11975057 core:AfterOneYear 2024-03-31 11975057 bus:EntityAccountantsOrAuditors 2023-06-01 2024-03-31 11975057 core:PlantMachinery 2024-04-01 2025-03-31 11975057 core:PlantMachinery 2025-03-31 11975057 core:PlantMachinery 2024-03-31 11975057 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-03-31 11975057 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-03-31 11975057 core:CostValuation core:Non-currentFinancialInstruments 2025-03-31 11975057 core:CostValuation core:Non-currentFinancialInstruments 2024-03-31 11975057 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-03-31 11975057 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-03-31 11975057 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-03-31 11975057 core:Non-currentFinancialInstruments 2025-03-31 11975057 core:Non-currentFinancialInstruments 2024-03-31 11975057 core:ShareCapital 2025-03-31 11975057 core:ShareCapital 2024-03-31 11975057 core:RetainedEarningsAccumulatedLosses 2025-03-31 11975057 core:RetainedEarningsAccumulatedLosses 2024-03-31 11975057 dpl:Item1 2024-04-01 11975057 dpl:Item1 2025-03-31 11975057 dpl:Item1 2023-06-01 11975057 dpl:Item1 2024-03-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 11975057
England and Wales

 

 

 

HAROON AND SONS MEDICAL SERVICES LIMITED



Abridged Accounts
 


Period of accounts

Start date: 01 April 2024

End date: 31 March 2025
 
 
Notes
 
2025
£
  2024
£
Fixed assets      
Tangible fixed assets 3 721    1,298 
Investments 4 13,017    12,150 
13,738    13,448 
Current assets      
Cash at bank and in hand 15,765    15,085 
Creditors: amount falling due within one year (24,491)   (11,574)
Net current assets (8,726)   3,511 
 
Total assets less current liabilities 5,012    16,959 
Creditors: amount falling due after more than one year   (60)
Net assets 5,012    16,899 
 

Capital and reserves
     
Called up share capital 2    2 
Profit and loss account 5,010    16,897 
Shareholders' funds 5,012    16,899 
 


For the year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the director on 30 December 2025 and were signed by:


-------------------------------
Ishrat Muhammad YOUSUF
Director
1
General Information
HAROON AND SONS MEDICAL SERVICES LIMITED is a private company, limited by shares, registered in England and Wales, registration number 11975057, registration address 635 CHATSWORTH ROAD, CHESTERFIELD, S40 3NT.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Plant and Machinery 6.67 Years Straight Line
Fixed asset investments
Fixed asset investments are stated at cost less provision for any permanent diminution in value.
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
2.

Average number of employees

Average number of employees during the year was 1 (2024 : 1).
3.

Tangible fixed assets

Cost or valuation Plant and Machinery   Total
  £   £
At 01 April 2024 3,850    3,850 
Additions  
Disposals  
At 31 March 2025 3,850    3,850 
Depreciation
At 01 April 2024 2,552    2,552 
Charge for year 577    577 
On disposals  
At 31 March 2025 3,129    3,129 
Net book values
Closing balance as at 31 March 2025 721    721 
Opening balance as at 01 April 2024 1,298    1,298 


4.

Investments

Cost Other investments other than loans   Total
  £   £
At 01 April 2024 12,150    12,150 
Additions 29,726    29,726 
Disposals (28,859)   (28,859)
At 31 March 2025 13,017    13,017 

2